Efficacy, safety and satisfaction of using emicizumab in hemophilia A patients without factor VIII inhibitors: A systematic review

Efficacy, safety and satisfaction of using emicizumab in hemophilia A patients without factor VIII inhibitors: A systematic review

Background: Hemophilia A is a genetic disorder characterized by deficiency or dysfunction of the factor VIII clotting protein, leading to serious bleeding disorders. Conventional treatment involves the exogenous administration of factor VIII. However, this therapy faces significant challenges, inclu...

Full description

Saved in:
Bibliographic Details
Main Authors: Isabela de Oliveira Araujo, Lucas Fernandes Suassuna, Isabela Lima dos Santos, Daniela de Oliveira Werneck Rodrigues
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Hemophilia A
Emicizumab
Bleeding disorders
Factor VIII deficiency
Patient satisfaction
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137925001178
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2531137925001178

Similar Items